% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • bioimmunomabman bioimmunomabman May 8, 2013 12:26 PM Flag

    Desperate VVUS not a plus for ARNA

    Why: 1) potential for price cutting 2) potential they get a sales partner 3) VVUS sales failure places the burden of proof on ARNA sales, people will not buy on the come since the VVUS product failed. Impatient ARNA shareholders will have to wait for their potential reward. With the biotech market up big and ARNA down this year, investors do not want to be patient.

    Looks like another good VVUS shorting opportunity IMO, they will either be sold to a sucker, or file ch 11.

1.55-0.02(-1.27%)Aug 31 4:00 PMEDT